Insider Purchase by FORSYTH DOUGLAS (Dir)
Trade Summary
2 days ago, FORSYTH DOUGLAS, serving as Dir at Inhibrx Biosciences, Inc. (INBX), purchased 2,500 shares at $114.65 per share, for a total transaction value of $286,617.25. Following this transaction, FORSYTH DOUGLAS now holds 227,064 shares of INBX.
This purchase represents a 1.11% increase in FORSYTH DOUGLAS's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 4:26 PM ET, meaning the disclosure happened on the same day as the trade.
Inhibrx Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$114.65
Quantity
2,500
Total Value
$286,617.25
Shares Owned
227,064
Trade Date
2 days ago
SEC Filing Date
at 4:26 PM ET
Discussion